Bactrim (Trimethoprim-Sulfamethoxazole) Use in Pregnancy
Trimethoprim-sulfamethoxazole (TMP-SMX/Bactrim) should be avoided during pregnancy, particularly near delivery, and used only when no safer alternatives exist for serious bacterial infections. 1
Safety Profile and Timing Considerations
First Trimester
- TMP-SMX is classified as a second-line agent during pregnancy and should be avoided when possible 2
- Trimethoprim interferes with folic acid metabolism, raising theoretical concerns about neural tube defects 2
- Use only if penicillins, cephalosporins, and other first-line agents have failed or are contraindicated 2
Near Delivery (Third Trimester)
- Sulfonamides carry a theoretical increased risk for neonatal hyperbilirubinemia and kernicterus when used near delivery 1
- Neonatal care providers must be informed if maternal sulfa therapy is used near delivery to monitor for these complications 1
- This risk is particularly concerning in the peripartum period 1
Preferred Alternatives During Pregnancy
First-Line Antibiotics
- Beta-lactam antibiotics (penicillins and cephalosporins) are the preferred first-line agents throughout pregnancy 1, 2, 3
- Penicillins have an established safety profile and should be used preferentially 4, 2
- First-generation cephalosporins (e.g., cefazolin) are appropriate alternatives for non-anaphylactic penicillin allergy 4, 5
- Third-generation cephalosporins (ceftriaxone) provide broader coverage when needed 1, 6
Second-Line Options
- Azithromycin is safe and effective for many infections during pregnancy 1, 5
- Clindamycin can be used if bacterial isolates are susceptible, though it should be used cautiously during the first trimester 7, 3
- Metronidazole is permitted during pregnancy when indications are strictly verified 2, 3
When TMP-SMX May Be Considered
Acceptable Scenarios
- Serious bacterial enteric infections in HIV-infected pregnant women when organism susceptibility testing supports its use 1
- Life-threatening infections where no safer alternative exists and susceptibility testing confirms efficacy 2
- Treatment should be guided by drug susceptibility testing of cultured isolates 1
Clinical Monitoring
- If TMP-SMX must be used near delivery, coordinate closely with neonatal care providers 1
- Monitor newborns for signs of hyperbilirubinemia and kernicterus 1
Common Pitfalls to Avoid
- Do not use TMP-SMX as empiric first-line therapy during pregnancy 2, 3
- Avoid prescribing in the weeks immediately preceding delivery unless absolutely necessary 1
- Do not assume all antibiotics are equally safe—pregnancy requires specific antibiotic selection based on trimester and fetal risk 2, 8
- Remember that approximately 10% of patients report penicillin allergy, but over 90% are not truly allergic—verify allergy history before avoiding beta-lactams 5, 3
Antibiotics to Strictly Avoid in Pregnancy
- Tetracyclines are contraindicated after the fifth week of pregnancy due to fetal tooth staining and bone accumulation 1, 2, 3
- Fluoroquinolones should be strictly avoided despite limited human data showing no clear teratogenicity, as they remain contraindicated as a precautionary measure 2, 3
- Aminoglycosides should be reserved only for life-threatening maternal infections due to nephrotoxicity and ototoxicity risks 2, 3